SCHEMBL5403596

SCHEMBL5403596

Oc1ccc(-c2nc(Cn3ccnn3)cs2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.45
ATP4A P20648 1/20 0.42
ATP4B P51164 1/20 0.42
MAPT P10636 3/20 0.41
RAB9A P51151 1/20 0.41
DRD2 P14416 2/20 0.41
DRD4 P21917 2/20 0.41
DRD3 P35462 2/20 0.41
GFER P55789 2/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5400344 0.84 CYP19A1 (0.42) CYP19A1ATP4AATP4BRAB9ADRD2
SCHEMBL5403605 0.83 KDM4E (0.56) CYP19A1ATP4AATP4BMAPTRAB9A
SCHEMBL5401785 0.76 CYP19A1 (0.49) CYP19A1ATP4AATP4BMAPTRAB9A
SCHEMBL3115301 0.76 RAB9A (0.56) CYP19A1MAPTRAB9AKDM4ELMNA
SCHEMBL4564456 0.76 CYP19A1 (0.69) CYP19A1POLBALDH1A1HSP90AA1HSP90AB1
SCHEMBL5400311 0.73 CYP19A1 (0.42) CYP19A1DRD2DRD4DRD3LMNA
SCHEMBL27306341 0.71 RAB9A (0.57) CYP19A1MAPTRAB9AGFERKDM4E
SCHEMBL2706140 0.71 GFER (0.72) CYP19A1MAPTRAB9ADRD2DRD4
Bromide SCHEMBL9271730 0.70 RAB9A (0.55) CYP19A1MAPTRAB9AGFERKDM4E
SCHEMBL13201552 0.68 CYP19A1 (0.80) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259262-B2 Arylazole derivatives, their manufacture and use as pharmaceutical agents HOFFMANN-LA ROCHE INC. (US) 2007-08-21 US disclosed
CN-1867567-A 2-' (E) -2- (phenyl) vinyl-4- (arylalkoxy) -oxazole or-thiazole compounds as HER-2 tyrosine kinase inhibitors and their use in the treatment of cancer HOFFMANN LA ROCHE (CH) 2006-11-22 CN disclosed
EP-1680417-A1 1-'(E)-2-(PHENYL)ETHENYL-4-(ARYLALKOXY)-OXAZOLE OR -THIAZOLE COMPOUNDS AS HER-2 TYROSINE KINASES INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2006-07-19 EP disclosed
WO-2005040158-A1 1-′(E)-2-(PHENYL) ETHENYL-4-(ARYLALKOXY)-OXAZOLE OR - THIAZOLE COMPOUNDS AS HER-2 TYROSINE KINASES INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER F. HOFFMANN - LA ROCHE AG (CH) 2005-05-06 WO disclosed